These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

109 related items for PubMed ID: 1534145

  • 41.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 42. [Treatment of CMV retinitis with intravitreal foscarnet].
    Cochereau I, Belayachi N, Diraison C, Matheron S, Bouyer I, Hoang-Xuan T, Saimot AG, Coulaud JP.
    J Fr Ophtalmol; 1998 Dec; 21(10):723-6. PubMed ID: 10052044
    [Abstract] [Full Text] [Related]

  • 43. Foscarnet induction therapy for cytomegalovirus retinitis in AIDS: comparison of twice-daily and three-times-daily regimens.
    Katlama C, Dohin E, Caumes E, Cochereau-Massin I, Brancon C, Robinet M, Rogeaux O, Dahan R, Gentilini M.
    J Acquir Immune Defic Syndr (1988); 1992 Dec; 5 Suppl 1():S18-24. PubMed ID: 1318363
    [Abstract] [Full Text] [Related]

  • 44. Generalised cutaneous rash associated with foscarnet usage in AIDS.
    Green ST, Nathwani D, Goldberg DJ, Mack DJ, Kennedy DH.
    J Infect; 1990 Sep; 21(2):227-8. PubMed ID: 2146323
    [No Abstract] [Full Text] [Related]

  • 45. [AIDS. Combination therapy is more favorable].
    Fortschr Med; 1988 Sep 30; 106(28):57. PubMed ID: 3069665
    [No Abstract] [Full Text] [Related]

  • 46.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 47. Antiviral drugs for AIDS. Current status and future prospects.
    Sandström E.
    Drugs; 1986 Jun 30; 31(6):463-6. PubMed ID: 2942386
    [No Abstract] [Full Text] [Related]

  • 48. The treatment of HIV infection.
    Richman DD.
    AIDS; 1988 Jun 30; 2 Suppl 1():S137-42. PubMed ID: 2852501
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome.
    Montefiori DC, Robinson WE, Mitchell WM.
    AIDS Res Hum Retroviruses; 1989 Apr 30; 5(2):193-203. PubMed ID: 2469450
    [Abstract] [Full Text] [Related]

  • 51. Generalised cutaneous rash associated with foscarnet usage in AIDS.
    Blanshard C.
    J Infect; 1991 Nov 30; 23(3):336-7. PubMed ID: 1836487
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Antiviral therapy in AIDS. Clinical pharmacological properties and therapeutic experience to date.
    Sandström EG, Kaplan JC.
    Drugs; 1987 Sep 30; 34(3):372-90. PubMed ID: 2824170
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. The challenge of combination antiretroviral therapy for AIDS. An introduction.
    Groopman JE.
    Am J Med; 1991 Apr 10; 90(4A):1S. PubMed ID: 2018044
    [No Abstract] [Full Text] [Related]

  • 58. Pharmacokinetics of potential anti-AIDS agents thiofoscarnet and foscarnet in the cat.
    Straw JA, Loo TL, de Vera CC, Nelson PD, Tompkins WA, Bai SA.
    J Acquir Immune Defic Syndr (1988); 1992 Apr 10; 5(9):936-42. PubMed ID: 1387417
    [Abstract] [Full Text] [Related]

  • 59. New drugs on the horizon.
    el-Chaar GM, Schwenk MH, Bardini J, Caliendo G, Frank C, Profeta LM, Talbot KA, Cohen H.
    Clin Podiatr Med Surg; 1992 Apr 10; 9(2):481-501. PubMed ID: 1534032
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.